Also known as آسٹیوپوروسس مینجمنٹ
Internal Medicine Specialist
M.B.B.S, F.C.P.S (Medicine), MRCP (London), MRCPS (Glasgow), MRCP (Edinburgh)
Internal Medicine Specialist
M.B.B.S, F.C.P.S (Medicine), MRCP (London), MRCPS (Glasgow), MRCP (Edinburgh)
Internal Medicine Specialist
MBBS, MRCP (UK)
Consultant Physician
MBBS, FCPS (Medicine)
Internal Medicine Specialist
MBBS, FCPS (Medicine), M.D
Internal Medicine Specialist
MBBS, FCPS (Medicine)
Internal Medicine Specialist
M.B.B.S., F.C.P.S. (medicine)
Gastroenterologist
MBBS, Diplomate of American Board (Internal Medicine - USA), Diplomate of American Board (Gastroenterology - USA)
Gastroenterologist
MBBS, Diplomate of American Board (Internal Medicine - USA), Diplomate of American Board (Gastroenterology - USA)
Internal Medicine Specialist
MBBS, FCPS (Medicine)
Internal Medicine Specialist
MBBS, American Diplomate,Board of Critical care Medicine, Internal Medicine, Infectious Diseases
Internal Medicine Specialist
MBBS, American Diplomate,Board of Critical care Medicine, Internal Medicine, Infectious Diseases
Bisphosphonates are used as first-line pharmacologictreatment for osteoporosis. In patients who cannot tolerate or whose symptoms do not improve with bisphosphonate therapy, teriparatide (Forteo) and denosumab (Prolia) are effective alternative medications to prevent osteoporotic fractures